Turns out allergies and autoimmune diseases aren't as different as we thought. Growing research reveals they share inflammatory pathways, genetic vulnerabilities, and environmental triggers — especially damage to the epithelial barrier. This overlap is pushing clinicians to screen more broadly and opening doors to repurposing treatments across both disease types.
For decades, allergies and autoimmune diseases were treated as opposites — one an overreaction to harmless substances, the other an attack on the body's own tissues. But a wave of new research is blurring that line, showing the two conditions frequently co-occur and may stem from the same underlying immune dysfunction, including shared inflammatory pathways, genetic susceptibilities, and failures in immune tolerance.
A key suspect? The epithelial barrier — the protective cell lining of the skin, gut, and respiratory tract. Everyday chemicals like cleaning surfactants, microplastics, and food emulsifiers may damage this barrier, allowing allergens and microbes to trigger persistent inflammation. Shifts in the microbiome compound the problem, further disrupting the immune system's ability to tell friend from foe. Experts say this could explain why chronic allergic inflammation may prime the immune system for autoimmune responses over time.
By the Numbers
Why it matters: This paradigm shift could reshape how clinicians screen and treat patients — prompting broader questioning about overlapping symptoms and opening the door to repurposing drugs like IL-5 inhibitors and JAK inhibitors across both disease categories.
